Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Cardiology
    • Endocrinology
    • Gastroentrology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Nephrology
    • Oncology
    • Primary Care
    • Rare Diseases
  • RESOURCES
  • CONTACT

Beyond AChR: Recognizing and Treating MuSK Ab+, LRP4, Ab+ and Triple Seronegative Myasthenia Gravis

  • Post author By salmocc
  • Post date September 8, 2026

Beyond AChR: Recognizing and Treating MuSK Ab+, LRP4, Ab+ and Triple Seronegative Myasthenia Gravis

 Rare Diseases

Physicians:

American Academy of CME, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other HCPs
Other members of the care team will receive a certificate of participation.

  • Listing ID: 3543

← Cornerstones Best of Digestive Disease Week in Inflammatory Bowel Disease 2026: Translating DDW Into Clinical Practice